Beraprost enhances the APC function of B cells by upregulating CD86 expression levels

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Lipid mediators play crucial roles in immune system regulation.
• Prostacyclin synthase is highly expressed in germinal centers, suggesting a role for prostacyclin in B cell function.

Purpose of the Study:

• To investigate the role of prostacyclin in regulating B cell antigen-presenting cell (APC) function.
• To explore the effects of a stable prostacyclin analog, beraprost, on B cell activation and costimulatory molecule expression.

Main Methods:

• Treatment of activated B cells with beraprost.
• Analysis of costimulatory molecule (CD86, CD80) expression using flow cytometry.
• Investigation of signaling pathways involving B cell receptor (BCR), CD40, and prostacyclin receptor (IP).
• Assessment of T cell stimulation by beraprost-treated B cells.

Main Results:

• Beraprost significantly increased CD86 expression on activated B cells in a time- and dose-dependent manner.
• The effect of beraprost was specific to activated B cells and not observed on memory B cells, centroblasts, or centrocytes.
• Beraprost-induced CD86 upregulation required BCR and CD40 signaling and involved the prostacyclin receptor (IP) and increased intracellular cAMP.
• B cells treated with beraprost showed enhanced stimulation of allogeneic T cells, which was abrogated by CD86 neutralization.

Conclusions:

• Prostacyclin, via beraprost, enhances the APC function of B cells by upregulating CD86 expression.
• This mechanism highlights a previously unrecognized role for prostacyclin in regulating germinal center reactions and T cell responses.
• The findings suggest potential therapeutic strategies targeting prostacyclin pathways in immune modulation.